Algorithmic fairness in cardiovascular disease risk prediction: overcoming inequalities

Tibor V Varga1

  • 1Section of Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmark Tibor.Varga@sund.ku.dk.

Open Heart
|November 14, 2023
PubMed

Insights

Current cardiovascular risk models like SCORE2 overlook socioeconomic factors, potentially causing health disparities. Including these determinants may improve risk prediction and promote health equity in cardiovascular disease management.

Area of Science:

  • Cardiovascular Disease Research
  • Health Equity Studies
  • Biostatistics and Predictive Modeling

Background:

  • Prognostic risk prediction models aim to identify at-risk individuals for early intervention.
  • Existing cardiovascular risk models (e.g., SCORE2, SCORE2-OP) are the EU standard but often neglect socioeconomic determinants.
  • This oversight can lead to disparities in risk prediction and healthcare resource allocation.

Purpose of the Study:

  • To highlight the limitations of current cardiovascular risk prediction models in addressing socioeconomic factors.
  • To advocate for the explicit inclusion of individual-level socioeconomic determinants in cardiovascular disease risk models.
  • To explore the potential of fairness concepts in cardiovascular disease prediction to reduce health disparities.

Main Methods:

  • Review of current prognostic cardiovascular risk prediction models and their methodologies.
  • Analysis of socioeconomic determinants' impact on cardiovascular disease risk.
  • Introduction and conceptualization of four distinct fairness concepts applied to cardiovascular disease prediction.

Main Results:

  • Current gold-standard models (SCORE2, SCORE2-OP) generally overlook socioeconomic determinants.
  • This omission contributes to disparities in cardiovascular risk prediction and resource allocation.
  • The paper introduces fairness concepts as a potential tool to mitigate these disparities.

Conclusions:

  • Explicitly incorporating socioeconomic determinants into cardiovascular risk models is a key recommendation.
  • The potential for these enhanced models to promote health equity requires further investigation through research and implementation.
  • Fairness concepts offer a framework for developing more equitable cardiovascular disease prediction tools.

Related Concept Videos

Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
306
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
17
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
104
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
191
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
133
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23